Altimmune, Inc. (ALT)
Market Closed
17 Jul, 20:00
$
2. 87
+0.02
+0.7018%
$
251.53M Market Cap
- P/E Ratio
11.64% Div Yield
2.96M Volume
-1.47 Eps
$ 2.85
Previous Close 
Want to track ALT and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Altimmune, Inc. (ALT) Statistics
Valuation metrics
Market Cap 251.53M
Enterprise value 191.54M
Trailing P/E (ttm) -3.09
Forward P/E -3.04
PEG ratio -0.09
Price/Sales (ttm) 7,036.07
Price/Book (mrq) 1.26
Enterprise Value/Revenue 5,320.68
Enterprise Value/EBITDA -2.17
Overview
Shares outstanding 130.22M
Float 164.14M
Shares short 35.45M
% Held by insiders 0%
% Held by institutions 0.55%
Average volume (10 days) 2.96M
Average volume (90 days) 4.69M
Price summary
52-Week low 2.56
52-Week high 6.44
Beta 0.17
50-Day moving average 2.81
200-Day moving average 3.73
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date 3 Feb 2017
Ex-Dividend Date 20 Jan 2017
Last split factor 1:30
Last split Date 14 Sep 2018
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin -2,530.03%
Operating margin -2,692.17%
Operational effectiveness
Return on assets -0.27%
Return on equity -0.43%
Income Statement
Revenue (ttm) 36K
Revenue per share (ttm) 0
Quarterly revenue growth (yoy) -1%
Gross profit (ttm) -66.05M
EBITDA -96.1M
Net income to common (ttm) -91.08M
Diluted EPS (ttm) -0.73
Quarterly earnings growth (yoy) -1%
Balance Sheet
Total cash (mrq) 331.54M
Total cash per share (mrq) 2.66
Total debt (mrq) 35.85M
Total Debt/Equity (mrq) 0.13
Current ratio (mrq) 29.56%
Book value per share (mrq) 2.28
Cash Flow
Cash flow statement -71.64M
Levered free cash flow (LFCF) -42.5M
